There was a nonsignificant trend in favour of DI-EC with respect to disease-free survival.
← all excerpts
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
1
—
—